STELLA PHARMA CORPORATION Financial Overview
STELLA PHARMA CORPORATION's market cap is currently ¥10.58B. The company's EPS TTM is ¥-4.45; its P/E ratio is -77.98; STELLA PHARMA CORPORATION is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
